Cardiovascular effects of phenothiazines.
D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects; D002315:Cardiopulmonary Bypass; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System / Q000187:drug effects*; D002746:Chlorpromazine / Q000627:therapeutic use; D004285:Dogs; D004562:Electrocardiography; D004594:Electrophysiology; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D010640:Phenothiazines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011652:Pulmonary Circulation / Q000187:drug effects; D012770:Shock, Cardiogenic / Q000188:drug therapy; D012771:Shock, Hemorrhagic / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D010640:Phenothiazines; D002746:Chlorpromazine